Compugen (CGEN) Depreciation and Depletion (2009 - 2010)
Compugen's (CGEN) quarterly Depreciation and Depletion came in at $50000.0 in Q4 2010, up 316.67% year-on-year from $12000.0 in Q4 2009, and down 1.96% quarter-over-quarter from $51000.0 in Q3 2010.
Compugen (CGEN) Depreciation and Depletion (2009 - 2010) Analysis & Trends
Compugen has disclosed Depreciation and Depletion across 2 years of filings, most recently posting $50000.0 for Q4 2010.
- Depreciation and Depletion for Q4 2010 came in at $50000.0, up 316.67% year-over-year; the trailing twelve-month figure through Dec 2010 was $161000.0 (changed N/A YoY), and the FY2025 annual result was $475000.0, down 2.26% from the prior year.
- Depreciation and Depletion came in at $50000.0 for Q4 2010 at Compugen, down from $51000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $51000.0 in Q3 2010 to a low of $12000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 50,000.00 |
| Dec 31, 2010 | 50,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Sep 30, 2009 | 48,000.00 |
| Sep 30, 2009 | 48,000.00 |